scholarly article | Q13442814 |
P356 | DOI | 10.1177/1479164111424762 |
P698 | PubMed publication ID | 22058089 |
P50 | author | Torben Jørgensen | Q7825461 |
Leif Groop | Q27214742 | ||
Torben Hansen | Q29583803 | ||
Oluf Borbye Pedersen | Q29583849 | ||
P2093 | author name string | Knut Borch-Johnsen | |
Valeria Lyssenko | |||
Janice Kolberg | |||
Michael P McKenna | |||
Robert W Gerwien | |||
Michael W Rowe | |||
P2860 | cites work | Clinical risk factors, DNA variants, and the development of type 2 diabetes | Q34884389 |
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies | Q36839519 | ||
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort | Q37235925 | ||
Validation of a multimarker model for assessing risk of type 2 diabetes from a five-year prospective study of 6784 Danish people (Inter99). | Q37404546 | ||
Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? | Q43960351 | ||
An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes | Q44040130 | ||
Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women | Q44114894 | ||
The diabetes risk score: a practical tool to predict type 2 diabetes risk | Q44333486 | ||
A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. | Q44685218 | ||
Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes | Q45199153 | ||
Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years. | Q45987114 | ||
Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. | Q51465708 | ||
Short-term variability in measures of glycemia and implications for the classification of diabetes. | Q51467211 | ||
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. | Q51470643 | ||
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
Progression from newly acquired impaired fasting glusose to type 2 diabetes | Q24683882 | ||
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 | ||
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 | ||
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
Implications of alternative definitions of prediabetes for prevalence in U.S. adults | Q34507171 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type 2 diabetes | Q3025883 |
P304 | page(s) | 59-67 | |
P577 | publication date | 2011-11-04 | |
P1433 | published in | Diabetes and Vascular Disease Research | Q5270121 |
P1476 | title | Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies. | |
P478 | volume | 9 |
Q38009358 | 'Omics'-driven discoveries in prevention and treatment of type 2 diabetes |
Q91945035 | A Review of Recent Evidence from Meal-Based Diet Interventions and Clinical Biomarkers for Improvement of Glucose Regulation |
Q38596433 | An exploratory retrospective assessment of a quantitative measure of diabetes risk: medical management and patient impact in a primary care setting |
Q35581227 | Biomarker models as surrogates for the disposition index in the Insulin Resistance Atherosclerosis Study |
Q57012108 | Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol |
Q41634378 | Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solution |
Q38404230 | Performance of a multi-marker diabetes risk score in the Insulin Resistance Atherosclerosis Study (IRAS), a multi-ethnic US cohort |
Q49438496 | Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis |
Q35189544 | Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics |
Q56974269 | Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells |
Q38146916 | The potential of novel biomarkers to improve risk prediction of type 2 diabetes |
Q35229122 | The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes |